Back

PANTHER - P2Y12 inhibitor or Aspirin moNoTHERapy as secondary prevention in patients with coronary artery disease

31 August 2025 (18:00 - 18:15)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Trials: coronary artery disease and interventions Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Marco Valgimigli

Cardiocentro Ticino Institute, Lugano (Switzerland)

3 More presentations in this session

Presentation thumbnail
MACROS-2: RCT of ESC 0/1 versus 0/3 hour ADP for suspected ACS
Doctor J. Hatherley (Liverpool, GB)
Slides Video
Presentation thumbnail
Complete revascularisation versus usual care in non-STEMI with multivessel disease: results from the SLIM study
Mr T. Pustjens (Maastricht, NL)
Slides Video
Presentation thumbnail
PIONEER IV trial primary report
Professor P. Serruys (Galway, IE)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Trials: coronary artery disease and interventions
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 18:00 CET
You may be interested in
thumbnail
Congress Session
Late-Breaking Clinical Trials: coronary artery disease and interventions
thumbnail
Congress Session
Novel antiplatelet approaches following acute coronary syndromes or percutaneous coronary intervention
thumbnail
Congress Presentation
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources